Sana Biotechnology, Inc.
SANA
$3.58
-$0.02-0.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -9.95% | -33.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.64% | -5.97% | |||
| Operating Income | 9.64% | 5.97% | |||
| Income Before Tax | -89.92% | -0.65% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -89.92% | -0.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -89.92% | -0.65% | |||
| EBIT | 9.64% | 5.97% | |||
| EBITDA | 8.67% | 6.13% | |||
| EPS Basic | -89.23% | -0.10% | |||
| Normalized Basic EPS | 10.08% | -3.73% | |||
| EPS Diluted | -89.23% | 0.00% | |||
| Normalized Diluted EPS | 10.08% | -3.73% | |||
| Average Basic Shares Outstanding | 0.35% | 0.54% | |||
| Average Diluted Shares Outstanding | 0.35% | 0.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||